Carmen Crespo

Randomized Phase 3 Trial of Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer

Miguel Martín, Álvaro Rodríguez-Lescure, A. Ruiz et al. · JNCI Journal of the National Cancer Institute · 2008 · 238 citations · Full text

Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2− breast cancer patients: results from the GEICAM 9906 trial

Miguel Martín, Jan C. Brase, Lourdes Calvo et al. · Breast Cancer Research · 2014 · 160 citations · Full text

Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer

Miguel Martín, Álvaro Rodríguez-Lescure, Emilio Alba et al. · Breast Cancer Research and Treatment · 2009 · 81 citations

Breast Oncology, Oncology, Early Breast Cancer +7

Fluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus FAC Followed by Weekly Paclitaxel As Adjuvant Therapy for High-Risk, Node-Negative Breast Cancer: Results From the GEICAM/2003-02 Study

Miguel Martín, Manuel Ruíz Borrego, Agustí Barnadas et al. · Journal of Clinical Oncology · 2013 · 56 citations · Full text

The use of continuous vs. intermittent cold water immersion as a recovery method in basketball players after training: A randomized controlled trial

Braulio Sánchez‐Ureña, Ismael Martínez‐Guardado, Carmen Crespo et al. · The Physician and Sportsmedicine · 2017 · 30 citations